386 related articles for article (PubMed ID: 24398331)
21. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F; Gambineri E; Favre C
Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
[TBL] [Abstract][Full Text] [Related]
22. [A case of autoimmune lymphoproliferactive syndrome and literature review].
Liu L; Hu J; Ma J; Li X; Li F; Li C
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
Jackson CE; Fischer RE; Hsu AP; Anderson SM; Choi Y; Wang J; Dale JK; Fleisher TA; Middelton LA; Sneller MC; Lenardo MJ; Straus SE; Puck JM
Am J Hum Genet; 1999 Apr; 64(4):1002-14. PubMed ID: 10090885
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
Front Immunol; 2019; 10():1193. PubMed ID: 31191551
[TBL] [Abstract][Full Text] [Related]
25. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
[TBL] [Abstract][Full Text] [Related]
26. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
[TBL] [Abstract][Full Text] [Related]
27. How I treat autoimmune lymphoproliferative syndrome.
Rao VK; Oliveira JB
Blood; 2011 Nov; 118(22):5741-51. PubMed ID: 21885601
[TBL] [Abstract][Full Text] [Related]
28. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
[TBL] [Abstract][Full Text] [Related]
29. A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.
Lo B; Ramaswamy M; Davis J; Price S; Rao VK; Siegel RM; Lenardo MJ
J Clin Immunol; 2013 Feb; 33(2):479-88. PubMed ID: 23054345
[TBL] [Abstract][Full Text] [Related]
30. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
Teachey DT
Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
[TBL] [Abstract][Full Text] [Related]
31. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
Ben-Mustapha I; Agrebi N; Barbouche MR
J Leukoc Biol; 2018 Mar; 103(3):501-508. PubMed ID: 29345341
[TBL] [Abstract][Full Text] [Related]
32. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
[TBL] [Abstract][Full Text] [Related]
34. Why do T cells cause so much trouble?
McClain KL
Blood; 2014 Mar; 123(13):1978. PubMed ID: 24677399
[TBL] [Abstract][Full Text] [Related]
35. A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect.
Simesen de Bielke MG; Yancoski J; Rocco C; Pérez LE; Cantisano C; Pérez N; Oleastro M; Danielian S
J Clin Immunol; 2012 Dec; 32(6):1197-203. PubMed ID: 22752343
[TBL] [Abstract][Full Text] [Related]
36. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
Rieux-Laucat F; Magérus-Chatinet A; Neven B
J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
[TBL] [Abstract][Full Text] [Related]
37. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Magerus-Chatinet A; Neven B; Stolzenberg MC; Daussy C; Arkwright PD; Lanzarotti N; Schaffner C; Cluet-Dennetiere S; Haerynck F; Michel G; Bole-Feysot C; Zarhrate M; Radford-Weiss I; Romana SP; Picard C; Fischer A; Rieux-Laucat F
J Clin Invest; 2011 Jan; 121(1):106-12. PubMed ID: 21183795
[TBL] [Abstract][Full Text] [Related]
38. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
Rieux-Laucat F; Blachère S; Danielan S; De Villartay JP; Oleastro M; Solary E; Bader-Meunier B; Arkwright P; Pondaré C; Bernaudin F; Chapel H; Nielsen S; Berrah M; Fischer A; Le Deist F
Blood; 1999 Oct; 94(8):2575-82. PubMed ID: 10515860
[TBL] [Abstract][Full Text] [Related]
39. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation.
Hauck F; Magerus-Chatinet A; Vicca S; Rensing-Ehl A; Roesen-Wolff A; Roesler J; Rieux-Laucat F
Clin Immunol; 2013 Apr; 147(1):61-68. PubMed ID: 23524443
[TBL] [Abstract][Full Text] [Related]
40. The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome.
Jevtich K; Price S; Similuk M; Kulm E; Yan J; Setzer M; Jamal L; Franco LM; Ghosh R; Walkiewicz M; Rao VK
Blood Adv; 2022 Jul; 6(13):3974-3978. PubMed ID: 35476126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
